Daoyin Technique for Improving Exercise Endurance in IPF
Condition(s) studied
Investigational drug(s) / intervention(s)
Daoyin Technique: On the basis of treatment guided by "Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline ", the experimental group was given Daoyin Technique for treatment. For patients who are able to complete the respiratory guidance technique. For patients who are unable to complete the respiratory guidance technique but have stable vital signs (referring to the "Expert Consensus on Respiratory Critical Care Rehabilitation Treatment Techniques in China"), the supine guidance technique is selected. It is carried out 5 days a week, 2 times a day, and each training session lasts for 30 minutes.
Routine Comprehensive Training: On the basis of treatment guided by I"Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline",the experimental group was given Routine Comprehensive Training. According to the patient's condition, select aerobic training (such as walking) or upper - limb and lower - limb resistance training (such as lifting, chest - expanding, foot - pedaling movements, etc.) combined with respiratory training (such as pursed - lip breathing, abdominal breathing, etc.). The heart rate should reach the target heart rate range and last for more than 10 minutes. This training is carried out 5 days a week, 2 times a day.
Study summary
This study is based on the previously constructed digital rehabilitation management platform, scientifically evaluating the clinical efficacy of guided technology in improving IPF exercise endurance, and forming high-quality clinical evidence.
Eligibility
Primary outcome measure(s)
- 6 Six Minute Walk Distance(6MWD) — Change from baseline 6MWD at week 13 and 26.
6MWD will be applied to evaluate the exercise capacity. The higher values indicate the better exercise capacity. - the 30 - second sit - to - stand test(30s STS) — Change from baseline FVC at week 13 and 26.
30s STS will be used to assess pulmonary function.
Trial sites (3)
| Facility | City | Region | Status |
|---|---|---|---|
| Xiyuan Hospital of China Academy of Chinese Medical Sciences | Beijing | Beijing Municipality | Recruiting |
| The First Affiliated Hospital of Henan University of Traditional Chinese Medicine | Zhengzhou | Henan | Recruiting |
| The Affiliated Hospital of Liaoning University of Traditional Chinese Medicinenese Medicine | Shenyang | Liaoning | Recruiting |
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07019714 on ClinicalTrials.gov ↗ ← All trials in China